Publications by authors named "Johan Richter"

Claim this Profile
M
Mapping brain tumor microstructure: A multimodal study of diffusion MRI, intraoperative fluorescence, and neuropathology in navigated biopsies.
Elisabeth Klint, Johan Richter, Teresa Nordin, Ida Blystad, Martin Hallbeck

Neuroimage Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.
Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross, Henrik Hjorth-Hansen, Andreas Hochhaus, Johan Richter

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative MRI relaxometry in brain tumor needle biopsies: Multimodal comparison with tissue fluorescence, radiology, and neuropathology.
Elisabeth Klint, Anders Tisell, Ida Blystad, Martin Hallbeck, Teresa Nordin, Johan Richter

PLoS One· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probe-Based Fluorescence Spectroscopy for In Situ Brain Tumor Measurements During Resection and Needle Biopsies.
Karin Wårdell, Elisabeth Klint, Johan Richter

Biomedicines· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral Microcirculation: Progress and Outlook of Laser Doppler Flowmetry in Neurosurgery and Neurointensive Care.
Karin Wårdell, Johan Richter, Peter Zsigmond

Microcirculation· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response.
Rebecca Warfvinge, Linda Geironson Ulfsson, Parashar Dhapola, Fatemeh Safi, Mikael Sommarin, Johan Richter

Elife· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In situ optical feedback in brain tumor biopsy: A multiparametric analysis.
Elisabeth Klint, Johan Richter, Peter Milos, Martin Hallbeck, Karin Wårdell

Neurooncol Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.
Fabio Efficace, Francois-Xavier Mahon, Johan Richter, Alfonso Piciocchi, Marta Cipriani

Leukemia· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.
Francois-Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq, Andreas Hochhaus, Panayiotis Panayiotidis, Johan Richter

J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa

Leukemia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa

Leukemia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Johan Richter

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to interpret the EURO-SKI study and its treatment-free remission outcome. Reply to R.P. Gale and J. Chen.
Markus Pfirrmann, Susanne Saussele, François-Xavier Mahon, Johan Richter

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Insertion Stereotactic Brain Biopsy Using In Vivo Optical Guidance-A Case Study.
Karin Wårdell, Elisabeth Klint, Peter Milos, Johan Richter

Oper Neurosurg· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects.
Inge G P Geelen, Stein-Erik Gullaksen, Mette M Ilander, Ulla Olssen-Strömberg, Satu Mustjoki, Johan Richter

Ann Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Use of Frameless Neuronavigation and In Situ Optical Guidance in Brain Tumor Needle Biopsies.
Elisabeth Klint, Johan Richter, Karin Wårdell

Brain Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Spinal neurosurgery: radiculopathy and myelopathy].
Adrian Elmi Terander, Alba Corell, Saeed Shahidi, Johan Richter, Mattias Sköld

Lakartidningen· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.
Jani Huuhtanen, Mette Ilander, Bhagwan Yadav, Olli Mj Dufva, Hanna Lähteenmäki, Johan Richter

J Clin Invest· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.
Torsten Dahlén, Gustaf Edgren, Per Ljungman, Hjalmar Flygt, Johan Richter

Am J Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study.
Hjalmar Flygt, Stina Söderlund, Jesper Stentoft, Johan Richter, Perttu Koskenvesa

Eur J Haematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FluoRa - a System for Combined Fluorescence and Microcirculation Measurements in Brain Tumor Surgery.
Elisabeth Klint, Stina Mauritzon, Bengt Ragnemalm, Johan Richter, Karin Wardell

Annu Int Conf IEEE Eng Med Biol Soc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical Brain Biopsy with a Fluorescence and Vessel Tracing Probe.
Johan Richter, Neda Haj-Hosseini, Peter Milos, Martin Hallbeck, Karin Wårdell

Oper Neurosurg· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI.
Johan Richter, Anna Lübking, Stina Söderlund, Kourosh Lotfi, Berit Markevärn

Leukemia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.
Hjalmar Flygt, Fredrik Sandin, Torsten Dahlén, Arta Dremaine, Anna Lübking, Johan Richter

Br J Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal.
Ilana Moscatelli, Elena Almarza, Axel Schambach, David Ricks, Ansgar Schulz, Johan Richter

Mol Ther Methods Clin Dev· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis